Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Brain Neoplasms
×
trastuzumab deruxtecan
×
Clear all
Filters
3
NCT04739761
2026-02-11
DESTINY-B12
AstraZeneca
Phase 3
Active not recruiting
506 enrolled
27 charts
NCT04538742
2025-12-08
DB-07
AstraZeneca
Phase 1/2
Active not recruiting
245 enrolled